Significant new results from ONJCRI’s Phase II rare cancer clinical trial on combination immunotherapy in dMMR/MSI-H non-colorectal cancers have been published in @jamaoncology.com.

➡️ Learn more: jamanetwork.com/journals/jam...

#RareCancers #RareCancerTrial #ClinicalTrials #ONJCRI